AU521982B2 – Pharmaceuticals with urea incuusion compounds
– Google Patents
AU521982B2 – Pharmaceuticals with urea incuusion compounds
– Google Patents
Pharmaceuticals with urea incuusion compounds
Info
Publication number
AU521982B2
AU521982B2
AU48135/79A
AU4813579A
AU521982B2
AU 521982 B2
AU521982 B2
AU 521982B2
AU 48135/79 A
AU48135/79 A
AU 48135/79A
AU 4813579 A
AU4813579 A
AU 4813579A
AU 521982 B2
AU521982 B2
AU 521982B2
Authority
AU
Australia
Prior art keywords
incuusion
pharmaceuticals
urea
compounds
urea incuusion
Prior art date
1978-06-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU48135/79A
Other versions
AU4813579A
(en
Inventor
Peter James Ayres
Steven Leigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phares Pharmaceutical Research NV
Original Assignee
Rech Pharma S A Soc D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1978-06-16
Filing date
1979-06-15
Publication date
1982-05-13
1979-06-15
Application filed by Rech Pharma S A Soc D
filed
Critical
Rech Pharma S A Soc D
1979-12-20
Publication of AU4813579A
publication
Critical
patent/AU4813579A/en
1982-05-13
Application granted
granted
Critical
1982-05-13
Publication of AU521982B2
publication
Critical
patent/AU521982B2/en
1995-06-15
Anticipated expiration
legal-status
Critical
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
XSQUKJJJFZCRTK-UHFFFAOYSA-N
Urea
Chemical compound
NC(N)=O
XSQUKJJJFZCRTK-UHFFFAOYSA-N
0.000
title
1
239000004202
carbamide
Substances
0.000
title
1
150000001875
compounds
Chemical class
0.000
title
1
239000003814
drug
Substances
0.000
title
1
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/0012—Galenical forms characterised by the site of application
A61K9/0014—Skin, i.e. galenical aspects of topical compositions
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
A61K9/1605—Excipients; Inactive ingredients
A61K9/1617—Organic compounds, e.g. phospholipids, fats
B—PERFORMING OPERATIONS; TRANSPORTING
B82—NANOTECHNOLOGY
B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K9/00—Medicinal preparations characterised by special physical form
A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S424/00—Drug, bio-affecting and body treating compositions
Y10S424/15—Suppositories
AU48135/79A
1978-06-16
1979-06-15
Pharmaceuticals with urea incuusion compounds
Expired
AU521982B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB7827115
1978-06-16
GB2711578
1978-06-16
Publications (2)
Publication Number
Publication Date
AU4813579A
AU4813579A
(en)
1979-12-20
AU521982B2
true
AU521982B2
(en)
1982-05-13
Family
ID=10497995
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU48135/79A
Expired
AU521982B2
(en)
1978-06-16
1979-06-15
Pharmaceuticals with urea incuusion compounds
Country Status (7)
Country
Link
US
(2)
US4291062A
(en)
EP
(1)
EP0006724B1
(en)
JP
(1)
JPS557272A
(en)
AU
(1)
AU521982B2
(en)
CA
(1)
CA1114744A
(en)
DE
(1)
DE2964135D1
(en)
IE
(1)
IE48761B1
(en)
Families Citing this family (27)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
HU180183B
(en)
*
1980-12-19
1983-02-28
Chinoin Gyogyszer Es Vegyeszet
Process for preparing stable suppository compositions containing volatile and/or labile active substances
CA1207231A
(en)
*
1982-08-24
1986-07-08
Hans W. Zulliger
Medicated suppository
US4698359A
(en)
*
1982-08-24
1987-10-06
Cilag, Ag
Medicated suppository
US4518583A
(en)
*
1983-02-22
1985-05-21
Gallina Damian J
Hemorrhoid and anorectal disease treatment method
US4514384A
(en)
*
1983-03-14
1985-04-30
Gallina Damian J
Hemorrhoid treatment method
EP0145711A1
(en)
*
1983-06-10
1985-06-26
International Copper Association, Inc.
Copper complex for treating cancer
JPS6013720A
(en)
*
1983-07-01
1985-01-24
Nitto Electric Ind Co Ltd
Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator
US4590190A
(en)
*
1983-07-01
1986-05-20
Nitto Electric Industrial Co., Ltd.
Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
DE3413569A1
(en)
*
1984-04-11
1985-10-24
Röhm Pharma GmbH, 6108 Weiterstadt
PHARMACEUTICAL AGENT FOR PSORIASIS THERAPY
US4672078A
(en)
*
1985-07-03
1987-06-09
Schering-Plough Corporation
Urea stabilized with a lactone in various pharmaceutical and cosmetic preparations
DE3603859A1
(en)
*
1986-02-07
1987-08-13
Roehm Pharma Gmbh
WASHABLE TOPICAL PREPARATION FOR THERAPY OF PSORIASIS
DE3612305A1
(en)
*
1986-04-11
1987-10-22
Roehm Pharma Gmbh
LIQUID MEDICINE FOR THERAPY OF PSORIASIS BASED ON FILM-FORMING POLYMERS
USH672H
(en)
1986-12-31
1989-09-05
E. R. Squibb & Sons, Inc.
Stable antifungal capsule formulation
GB8729855D0
(en)
*
1987-12-22
1988-02-03
Drythanol Ltd
New dithranol compositions
US5674504A
(en)
*
1989-07-12
1997-10-07
L’oreal
Cosmetic composition in the form of an aqueous gel containing in suspension spheroids of a non-hydrophilic, lipoidal substance
FR2649608B1
(en)
*
1989-07-12
1991-10-11
Oreal
COSMETIC COMPOSITION IN THE FORM OF AN AQUEOUS GEL CONTAINING SUSPENSION SPHEROIDS OF A NON-HYDROPHILIC SOLID LIPID SUBSTANCE
CA2116621C
(en)
*
1993-03-03
2001-07-24
Rene C. Gaudreault
Novel anticancer agents
TW360548B
(en)
*
1993-04-08
1999-06-11
Powderject Res Ltd
Products for therapeutic use
US5750547A
(en)
*
1995-01-06
1998-05-12
Universite Laval
Certain carbanate anti-cancer agents
EP1205218B1
(en)
*
2000-11-14
2004-03-31
Benkert, Eugen Georg, Dr.med.dent.
Topical antipsoriaticum comprising urea, a corticoid and a desinfectant
EP1214931A1
(en)
*
2000-12-15
2002-06-19
Schering Aktiengesellschaft
Water-free skin care formulations comprising micronized urea and method of manufacturing the same
US20060078616A1
(en)
*
2004-08-30
2006-04-13
Georgewill Dawaye A
Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
DE102005045989A1
(en)
*
2005-09-27
2007-03-29
Koko Kosmetikvertrieb Gmbh & Co. Kg
Powder base, useful for e.g. protecting the skin from disorders, comprises e.g. protective material, mineral pigment, different organic materials, urea, antimicrobial-, antiseptic-, anitinflammatory- and itch protective- agents
DE102008006791B4
(en)
*
2008-01-30
2011-11-24
Lts Lohmann Therapie-Systeme Ag
Transdermal therapeutic system with urea component and method for its production
US20140350106A1
(en)
*
2013-05-22
2014-11-27
Professional Compounding Centers Of America
Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same
US20140348873A1
(en)
*
2013-05-22
2014-11-27
Professional Compounding Centers Of America
Urea-Silicone Gel for Hyperkeratosis Treatment
RU2730852C2
(en)
*
2018-10-08
2020-08-26
Лариса Викторовна Фортунская
Composition of ingredients for treating fungal skin diseases of feet and nails (versions)
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB804492A
(en)
*
1955-04-25
1958-11-19
Martin Ruben
Aminopyrine, caffeine or quinine hydrochloride inclusion compounds
GB1404583A
(en)
*
1971-10-08
1975-09-03
Vymatt Sa
Urea compositions and methods of preparation thereof
GB1411432A
(en)
*
1972-01-10
1975-10-22
Medisan Ab
Skin treating compositions
JPS5210424A
(en)
*
1975-07-09
1977-01-26
Taisho Pharmaceut Co Ltd
A method for preparing a remedy against cutaneous fungi
1979
1979-06-15
DE
DE7979301159T
patent/DE2964135D1/en
not_active
Expired
1979-06-15
JP
JP7602279A
patent/JPS557272A/en
active
Pending
1979-06-15
EP
EP79301159A
patent/EP0006724B1/en
not_active
Expired
1979-06-15
AU
AU48135/79A
patent/AU521982B2/en
not_active
Expired
1979-06-15
US
US06/049,057
patent/US4291062A/en
not_active
Expired – Lifetime
1979-06-18
CA
CA329,970A
patent/CA1114744A/en
not_active
Expired
1979-08-08
IE
IE1172/79A
patent/IE48761B1/en
not_active
IP Right Cessation
1983
1983-09-21
US
US06/534,140
patent/USRE32161E/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
EP0006724A1
(en)
1980-01-09
US4291062A
(en)
1981-09-22
CA1114744A
(en)
1981-12-22
USRE32161E
(en)
1986-05-27
DE2964135D1
(en)
1983-01-05
IE791172L
(en)
1979-12-16
EP0006724B1
(en)
1982-12-01
AU4813579A
(en)
1979-12-20
JPS557272A
(en)
1980-01-19
IE48761B1
(en)
1985-05-15
Similar Documents
Publication
Publication Date
Title
AU521982B2
(en)
1982-05-13
Pharmaceuticals with urea incuusion compounds
AU4523779A
(en)
1979-09-27
Septum
AU520984B2
(en)
1982-03-11
Fastener
AU519405B2
(en)
1981-12-03
Producing urea granules
AU529840B2
(en)
1983-06-23
Urea and thiourea compounds
AU4389579A
(en)
1979-08-16
Quinazoline derivatives
AU525308B2
(en)
1982-10-28
Sliding-clasp fastener
AU4812279A
(en)
1980-01-03
Pallet construction using clip
AU522259B2
(en)
1982-05-27
Nitro compounds
AU525980B2
(en)
1982-12-09
Benzamide derivatives
AU529330B2
(en)
1983-06-02
Piperazinylbenzoheterocyclic compounds
AU4710179A
(en)
1979-11-22
Quinazoline derivatives
AU526183B2
(en)
1982-12-23
Sulfonato-organosilanol compounds
AU6027280A
(en)
1981-01-15
Ureas
GB2025406B
(en)
1982-11-03
Urea derivatives
AU5397579A
(en)
1980-07-03
Purifying insulin
AU6424480A
(en)
1981-05-14
Cyclic-substituted ureas
AU528403B2
(en)
1983-04-28
Flukicidal compounds
ZA793086B
(en)
1981-01-28
Urea derivatives
AU529907B2
(en)
1983-06-23
Oxadiazolotriazine pharmaceuticals
AU520081B2
(en)
1982-01-14
Furonaphthyridine compounds
AU522184B2
(en)
1982-05-20
Basically substituted urea derivatives
AU6426280A
(en)
1981-06-18
Urea assay
AU6491180A
(en)
1981-06-11
Pyridinopyrrolobenzenesulphonyl ureas
AU5183879A
(en)
1980-04-24
Urea dispenser
None